Work

COVID-19 and head and neck cancer treatment

Year: 2020

Type: article

Abstract: The coronavirus disease 2019 (COVID-19) pandemic is exponentially increasing, as are the risks of COVID-related complications and fatalities. Hence, health-care resources are being allocated for its management. Cancer treatment has taken a back seat in multiple countries due to resource scarcity and the risk of COVID-19-related complications. Head and neck cancer is no different. Probably, by the time COVID-related data get generated specifically for head and neck cancers, either the pandemic will be over, or it will be too late. Hence, there is an urgent need for guidance for head and neck cancer treatment in this situation. In this review article, we have provided evidence-based guidance for selecting the most appropriate therapy in the current pandemic situation.

Source: Cancer Research Statistics and Treatment

DOI: 10.4103/crst.crst_135_20

Authors: Kumar Prabhash, Vijay Patil, Vanita Noronha, Pankaj Chaturvedi, Kaustav Talapatra, Amit Joshi, Nandini Menon, Durgatosh Pandey

Institutions: Homi Bhabha National Institute, Tata Memorial Hospital, Kokilaben Dhirubhai Ambani Hospital, Mahamana Pandit Madan Mohan Malaviya Cancer Centre

Language: English

Topic: COVID-19 and healthcare impacts

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: diamond

OpenAlex ID: W3026823526

FWCI: 2.326

Cites: 123

Cited by: 29

Related to: 10